Base Genomics
Base Genomics is an epigenetics company focusing on developing a blood test for early-stage cancer and minimal residual disease.
Base Genomics has raised €9.8M across 1 funding round from 1 investor, most recently a Seed round in Mar 2020. Based in Oxford, UK; founded 2019; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€9.8M
€9,832,842
Funding rounds
1
Investors
1
distinct backers
Active since
2020-03
latest 2020-03
Funding by year
EUR raised per yearBase Genomics — funding by year — interactive chart.
Data table
| Base Genomics — funding by year | |
|---|---|
| 2020 | €9.8M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Seed
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-03-06 | Seed | €9.8M | Oxford Sciences Innovation | View deal → |